Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya

Journal of Infectious Diseases

Volumn 217, Issue 11, 2018, Pages 1728-1739

  Kiyuka, Patience K ^a   Agoti, Charles N ^a,b   Munywoki, Patrick K ^a   Njeru, Regina ^a   Bett, Anne ^a   Otieno, James R ^a   Otieno, Grieven P ^a   Kamau, Everlyn ^a   Clark, Taane G ^c   van der Hoek, Lia ^d   Kellam, Paul ^e,f   Nokes, D James ^a,g   Cotten, Matthew ^a,h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PWANI UNIVERSITY   (Kenya)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Kymab Ltd   (United Kingdom)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Coronavirus; Repeat infection; Virus evolution

Indexed keywords

SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRAL PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORONAVIRUS INFECTION; ENDEMIC DISEASE; EVOLUTION; FEMALE; GENE SEQUENCE; GENE SWITCHING; GENOTYPE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN CORONAVIRUS 229E; HUMAN CORONAVIRUS NL63; HUMAN CORONAVIRUS OC43; KENYA; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MONOPHYLY; NONHUMAN; NOSE SMEAR; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYLOGENY; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REINFECTION; SCHOOL CHILD; STUDENT T TEST; VIRUS EVOLUTION; WHOLE GENOME VIRUS SEQUENCING; GENETICS; HOSPITALIZATION; INFANT; NEWBORN; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL EVOLUTION; CHILD; CHILD, PRESCHOOL; CORONAVIRUS INFECTIONS; CORONAVIRUS NL63, HUMAN; CORONAVIRUS OC43, HUMAN; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALE; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PREVALENCE; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 85052015304     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy098     Document Type: Article

References (50)

1. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151–61.
2. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet 2011; 377:1264–75.
3. Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011; 52(Suppl 4):S284–9.
4. Berkley JA, Munywoki P, Ngama M, et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010; 303:2051–7.
5. Nokes DJ, Ngama M, Bett A, et al. Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis 2009; 49:1341–9.
6. Venter M, Lassaunière R, Kresfelder TL, Westerberg Y, Visser A. Contribution of common and recently described respiratory viruses to annual hospitalizations in children in South Africa. J Med Virol 2011; 83:1458–68.
7. Smuts H, Workman L, Zar HJ. Role of human metapneu-movirus, human coronavirus NL63 and human bocavirus in infants and young children with acute wheezing. J Med Virol 2008; 80:906–12.
8. Poon LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis 2004; 4:663–71.
9. Peiris JS, Lai ST, Poon LL, et al.; SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319–25.
10. de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013; 87:7790–2.
11. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814–20.
12. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368–73.
13. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010; 48:2940–7.
14. Garbino J, Crespo S, Aubert JD, et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin Infect Dis 2006; 43:1009–15.
15. Woo PC, Lau SK, Chu CM, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 2005; 79:884–95.
16. Owusu M, Annan A, Corman VM, et al. Human coronaviruses associated with upper respiratory tract infections in three rural areas of Ghana. PLoS One 2014; 9:e99782.
17. Dominguez SR, Robinson CC, Holmes KV. Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado. J Med Virol 2009; 81:1597–604.
18. Plotkin S. History of vaccination. Proc Natl Acad Sci U S A 2014; 111:12283–7.
19. Riedel S. Edward Jenner and the history of smallpox and vaccination. Proceedings 2005; 18:21–5.
20. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994; 19:500–12.
21. Yang ZY, Werner HC, Kong WP, et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 2005; 102:797–801.
22. Yip MS, Leung NH, Cheung CY, et al. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J 2014; 11:82.
23. Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 2004; 78:12672–6.
24. Peiris JS, Porterfield JS. Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines. Nature 1979; 282:509–11.
25. Sullivan NJ. Antibody-mediated enhancement of viral disease. Curr Top Microbiol Immunol 2001; 260:145–69.
26. Agoti CN, Mwihuri AG, Sande CJ, et al. Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis 2012; 206:1532–41.
27. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life. J Infect Dis 2004; 190:1828–32.
28. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis 2008; 46:50–7.
29. Munywoki PK, Koech DC, Agoti CN, et al. The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya. J Infect Dis 2014; 209:1685–92.
30. Agoti CN, Otieno JR, Ngama M, et al. Successive respiratory syncytial virus epidemics in local populations arise from multiple variant introductions, providing insights into virus persistence. J Virol 2015; 89:11630–42.
31. Hammitt LL, Kazungu S, Morpeth SC, et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis 2012; 54(Suppl 2):S190–9.
32. Driscoll AJ, Karron RA, Morpeth SC, et al. Standardization of laboratory methods for the PERCH study. Clin Infect Dis 2017; 64:245–52.
33. Gunson RN, Collins TC, Carman WF. Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol 2005; 33:341–4.
34. Cotten M, Oude Munnink B, Canuti M, et al. Full genome virus detection in fecal samples using sensitive nucleic acid preparation, deep sequencing, and a novel iterative sequence classification algorithm. PLoS One 2014; 9:e93269.
35. Endoh D, Mizutani T, Kirisawa R, et al. Species-independent detection of RNA virus by representational difference analysis using non-ribosomal hexanucleotides for reverse transcription. Nucleic Acids Res 2005; 33:e65.
36. Watson SJ, Welkers MR, Depledge DP, et al. Viral population analysis and minority-variant detection using short read next-generation sequencing. Philos Trans R Soc Lond B Biol Sci 2013; 368:20120205.
37. Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–77.
38. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26:2460–1.
39. Katoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 2008; 9:286–98.
40. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731–9.
41. Kokot M, Dlugosz M, Deorowicz S. KMC 3: counting and manipulating k-mer statistics. Bioinformatics 2017; 33:2759–61.
42. Wu K, Li W, Peng G, Li F. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci U S A 2009; 106:19970–4.
43. Lin HX, Feng Y, Tu X, et al. Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. Virus Res 2011; 160:283–93.
44. Pyrc K, Dijkman R, Deng L, et al. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol 2006; 364:964–73.
45. Gerna G, Campanini G, Rovida F, et al. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 2006; 78:938–49.
46. Lau SK, Woo PC, Yip CC, et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006; 44:2063–71.
47. Koetz A, Nilsson P, Lindén M, van der Hoek L, Ripa T. Detection of human coronavirus NL63, human metapneu-movirus and respiratory syncytial virus in children with respiratory tract infections in south-west Sweden. Clin Microbiol Infect 2006; 12:1089–96.
48. Lu R, Yu X, Wang W, et al. Characterization of human coronavirus etiology in Chinese adults with acute upper respiratory tract infection by real-time RT-PCR assays. PLoS One 2012; 7:e38638.
49. Ren L, Gonzalez R, Xu J, et al. Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing, China. J Med Virol 2011; 83:291–7.
50. van der Hoek L, Ihorst G, Sure K, et al. Burden of disease due to human coronavirus NL63 infections and periodicity of infection. J Clin Virol 2010; 48:104–8.